April 26, 2023

What is Interim Talent and Fractional Hiring?

In today’s economy uncertainty seems to be the “new normal.” With the collapse of SVB and other investment and financial institutions teetering on the edge – […]
March 4, 2021

Decentralized Clinical Trials

By: Lea Wolfinger Decentralized Clinical Trials (DCT) have been labeled by many as a product of the pandemic, but in reality, it has been a topic […]
February 22, 2021

Immunotherapy and Cancer

By: Jim Rudman. Our immune systems are our built-in protection against infections and diseases, including cancer. Immune cells, as well as the elements they produce, travel […]
January 28, 2021

Teamwork is an Essential in Life Sciences and Biotech

By: Robert Ruth. Teamwork is essential in any industry; in the Life Sciences and Biotech industries, it’s the glue that ties everything together and generates answers. […]
December 1, 2020

The Race for Safe Vaccines

By Lea Wolfinger, VP Ashton Tweed Research and development for safe, reliable vaccines is typically a lengthy process – as in many years. Enter COVID-19 and, […]
November 23, 2020

Leadership Insight for Life Sciences

“The led must not be compelled; they must be able to choose their own leader.”                 – Albert Einstein Leadership […]
November 16, 2020

 4 Keys to Bridging the Digital Talent Gap at C-Level

By James Rudman. In this era of continual technological advances, one of the top challenges facing Life Science, biotech, and many industries is an ever-growing digital […]
October 22, 2020

Drug Research and Development – Finding the Post-COVID Normal

By Jordan Warshafsky. By April, merely a few weeks after the pandemic onset, surveys were already indicating that nearly 50% of research labs worldwide were forced […]
July 31, 2020

Life Sciences Fundraising in the Wake of COVID-19

By Jim Rudman, CEO, Ashton Tweed and Robert Dickey IV, Managing Director, Foresite Advisors, LLC See this article on LinkedIn. The coronavirus pandemic is just one […]
May 28, 2020

Going Virtual – Embracing Change in Clinical Trials

By Jim Rudman, CEO, Ashton Tweed See this article on LinkedIn. When Ed Seguine, CEO of Clinical Ink, joined the company in 2010, he saw that […]
January 24, 2020

AI in the Life Sciences – What’s all the Hype?

By Robert Ruth, Vice President & Managing Director, Ashton Tweed See this article on LinkedIn. The advancement and implementation of artificial intelligence (AI) has been a […]
November 18, 2019

Digital Health & Wearables Encourage Education & Prevention

By Jim Rudman, CEO, Ashton Tweed See this article on LinkedIn. An annual global survey conducted by the American College of Sports Medicine recently predicted that […]
September 3, 2019

Navigating Uncharted Territory: Top Advice from 3 Digital Health CEOs

By Ashley Phillips, Director of Executive Recruitment, Ashton Tweed See this article on LinkedIn. Digital health companies are on the rise and medtech funding is increasing globally. […]
April 19, 2019

Staying Focused in Today’s Exciting Life Science Industry

By Jim Rudman, CEO, Ashton Tweed See this article on LinkedIn. 3D printing, a technology invented by Charles Hull in the early 1980s, has been applied […]
July 20, 2018

Racing Against the Clock in the Life Sciences

By Jordan Warshafsky, Partner, Ashton Tweed See this article on LinkedIn. Time is of the essence in the life sciences industry, just as it is in […]
close up of scientist writing test results in lab



  • Put "N/A" if not applicable.

    Ashton Tweed Privacy Policy - Your information is kept confidential.
  • This field is for validation purposes and should be left unchanged.